We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
85 hedge funds and large institutions have $429M invested in Iovance Biotherapeutics in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
85% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 20
23% more capital invested
Capital invested by funds: $349M → $429M (+$79.3M)
1% more funds holding
Funds holding: 84 → 85 (+1)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
0.69% more ownership
Funds ownership: 76.4% → 77.09% (+0.69%)
30% less call options, than puts
Call options by funds: $178K | Put options by funds: $254K
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
85
Holders Change
+1
Holders Change %
+1.19%
% of All Funds
2.12%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
14
Increased
37
Reduced
20
Closed
13
Calls
$178K
Puts
$254K
Net Calls
-$76K
Net Calls Change
-$3.32M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$19.3M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$11.6M |
| 3 |
Millennium Management
New York
|
+$10.5M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.38M |
| 5 |
JP Morgan Chase
New York
|
+$4.37M |
Top Sellers
| 1 |
BlackRock
New York
|
-$10.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.56M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$4.04M |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$693K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$524K |
